ES355121A1 - Procedimiento para la preparacion de una vacuna libre de antigenos. - Google Patents

Procedimiento para la preparacion de una vacuna libre de antigenos.

Info

Publication number
ES355121A1
ES355121A1 ES355121A ES355121A ES355121A1 ES 355121 A1 ES355121 A1 ES 355121A1 ES 355121 A ES355121 A ES 355121A ES 355121 A ES355121 A ES 355121A ES 355121 A1 ES355121 A1 ES 355121A1
Authority
ES
Spain
Prior art keywords
antigen
informationally
viruses
influenza
competent cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES355121A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of ES355121A1 publication Critical patent/ES355121A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES355121A 1967-06-19 1968-06-18 Procedimiento para la preparacion de una vacuna libre de antigenos. Expired ES355121A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEJ0033936 1967-06-19

Publications (1)

Publication Number Publication Date
ES355121A1 true ES355121A1 (es) 1969-11-16

Family

ID=7204943

Family Applications (1)

Application Number Title Priority Date Filing Date
ES355121A Expired ES355121A1 (es) 1967-06-19 1968-06-18 Procedimiento para la preparacion de una vacuna libre de antigenos.

Country Status (13)

Country Link
AT (1) AT282821B (es)
BE (1) BE716806A (es)
BR (1) BR6899970D0 (es)
CH (1) CH513241A (es)
DE (1) DE1617545C2 (es)
DK (1) DK119724B (es)
ES (1) ES355121A1 (es)
FR (2) FR1588820A (es)
GB (1) GB1229888A (es)
IE (1) IE32140B1 (es)
IL (1) IL30168A (es)
NL (1) NL6808486A (es)
NO (1) NO124840B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754934A (fr) * 1969-08-16 1971-02-17 Jachertz Diether Procede de production enzymatique d'arn-messager
GB1594097A (en) 1976-12-16 1981-07-30 Int Inst Of Differentiation Production of specific immune nucleic acids cell dialysates and antibodies
DE3115559A1 (de) * 1981-04-16 1982-10-28 Kommanditgesellschaft Schwarzhaupt, 5000 Köln Hochgereinigte informatorische ribonukleinsaeure (i-rns), verfahren zur herstellung und verwendung derselben
GB2216416B (en) * 1988-03-11 1992-06-24 Sandoz Ltd Nucleobase source for the stimulation of the immune system
US6867195B1 (en) 1989-03-21 2005-03-15 Vical Incorporated Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected
US6214804B1 (en) 1989-03-21 2001-04-10 Vical Incorporated Induction of a protective immune response in a mammal by injecting a DNA sequence
US6673776B1 (en) 1989-03-21 2004-01-06 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery

Also Published As

Publication number Publication date
IL30168A0 (en) 1968-08-22
FR1588820A (es) 1970-03-16
IL30168A (en) 1973-05-31
DE1617545A1 (de) 1971-04-01
CH513241A (de) 1971-09-30
DK119724B (da) 1971-02-15
DE1617545C2 (de) 1983-11-03
NL6808486A (es) 1968-12-20
AT282821B (de) 1970-07-10
NO124840B (es) 1972-06-12
BE716806A (es) 1968-12-19
BR6899970D0 (pt) 1973-02-13
IE32140L (en) 1968-12-19
GB1229888A (es) 1971-04-28
FR7781M (es) 1970-03-23
IE32140B1 (en) 1973-04-18

Similar Documents

Publication Publication Date Title
Wiktor et al. Cultivation of rabies virus in human diploid cell strain WI-38
Wiktor et al. Human cell culture rabies vaccine: antibody response in man
Sundquist et al. Influenza virus ISCOMs: antibody response in animals
Webster et al. Potentiation of the immune response to influenza virus subunit vaccines
JP5712126B2 (ja) 遅延型追加刺激免疫処置に対する迅速な応答
US3959466A (en) Highly attenuated cytomegalovirus vaccine and production thereof
Atanasiu et al. Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons: Part 3
Nicholson et al. Immune responses of humans to a human diploid cell strain of rabies virus vaccine: lymphocyte transformation, production of virus-neutralizing antibody, and induction of interferon
Schoenbaum et al. Pseudorabies virus latency and reactivation in vaccinated swine
ES355121A1 (es) Procedimiento para la preparacion de una vacuna libre de antigenos.
US3927208A (en) Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them
Zinkernagel Antiviral T-cell memory?
Glasgow et al. Isoprinosine: lack of antiviral activity in experimental model infections
MOGABGAB Upper respiratory illness vaccines: Perspectives and trials
Holper et al. Further studies on multiplication, serology and antigenicity of 2060 and JH viruses
US3629413A (en) Polyvalent bovine vaccines and methods of making and using same
Norrby et al. Humoral immunity to canine distemper after immunization of dogs with inactivated and live measles virus
Millian et al. Antibody response of man to canine distemper virus
McNeill The antibody response of rabbits to inactivated vaccinia virus
McLaren et al. Immunity to influenza in ferrets: XI. Cross-immunity between A/Hong Kong/68 and A/England/72 viruses: serum antibodies produced by infection or immunization
Závadová et al. Preparation of antisera against the S antigen of influenza A virus by immunization of guinea pigs with internal S antigen
ES486441A0 (es) Metodo para preparar una vacuna que contiene virus desacti- vado de peritonilis infecciosa felina.
McLaren et al. Immunity to influenza in ferrets: XII. Immunization of ferrets with TNBP-split influenza virus vaccine
RU2183972C2 (ru) Способ получения высокоактивной специфической к вирусу классической чумы свиней сыворотки крови свиней
Schieble et al. Rhinoviruses: an antigenic study of the prototype virus strains